RÉSUMÉ DIGEST
ACT 224 (HB 521) 2024 Regular Session Freeman
Existing law generally prohibits an insurer offering life and long-term care insurance policies
or annuities contracts from considering, for insurance coverage or underwriting purposes, an
individual's or the individual's family member's participation in genetic or clinical research.
New law retains existing law and further prohibits the insurer from considering an
individual's or the individual's family member's genetic test.
Existing law prohibits an insurer from cancelling or refusing to renew an existing policy
based on the fact that an individual or the individual's family member requested or received
genetic services, or participated in genetic research, including clinical research that includes
genetic services.
New law retains existing law and further prohibits an insurer from limiting or denying
coverage, or increasing premium rates, based on the genetic testing of an individual or the
individual's family member.
Effective August 1, 2024.
(Amends R.S. 22:918(B)(1) and (C)(1) and (2))


Statutes affected:
HB521 Original: 22:918(C)(1)
HB521 Engrossed: 22:918(B)(1)
HB521 Enrolled: 22:918(B)(1)
HB521 Act : 22:918(B)(1)